Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

HCG Cancer Hospital Mumbai Treats 125+ Prostate Cancer Patients Without Surgery or Hospital Stay


News provided by

HCG Cancer Hospital

22 Sep, 2026, 11:58 IST

Share this article

Share toX

Share this article

Share toX

Advanced SBRT offers precise prostate cancer treatment in just five sessions, powered by Versa HD and CyberKnife Mumbai's first and only platform

MUMBAI, India, Sept. 22, 2026 /PRNewswire/ -- Prostate cancer treatment does not always require surgery or prolonged hospitalisation. At HCG Cancer Hospital Mumbai, more than 125 prostate cancer patients have been treated with Stereotactic Body Radiotherapy (SBRT) using the advanced Versa HD radiation platform. Selected patients have also received highly precise SBRT through CyberKnife, a robotic radiation delivery system.

Continue Reading
HCG Cancer Hospital team along with patients they successfully treated
HCG Cancer Hospital team along with patients they successfully treated

These advanced treatments have been used for selected patients across different prostate cancer risk categories, offering them an effective alternative to surgery based on their age, stage of cancer, overall health and individual treatment requirements.

According to the Global Cancer Observatory (GLOBOCAN 2022), International Agency for Research on Cancer (IARC–WHO), India recorded an estimated 37,948 new prostate cancer cases in 2022, with this number projected to reach approximately 82,252 annually by 2045, highlighting the growing importance of awareness about available treatment options.

SBRT delivers a highly focused dose of radiation directly to the tumour while minimising exposure to nearby healthy organs. For suitable patients, the treatment can be completed in just five sessions, usually on an outpatient basis. Unlike surgery, SBRT does not involve an incision or removal of the prostate. Patients generally do not require hospital admission and can return home after each treatment session.

HCG Cancer Hospital, Colaba, is home to Mumbai's first and only CyberKnife platform, further strengthening HCG Mumbai's capabilities in precision radiation oncology. CyberKnife combines robotic precision with advanced image guidance. It allows us to deliver highly focused radiation while protecting nearby organs. This technology is particularly useful when accuracy and the ability to account for internal movement are critical to treatment planning and delivery.

Dr Trinanjan Basu, HOD and Senior Consultant Radiation Oncology, HCG Cancer Hospitals, Mumbai, said, "Many patients believe that surgery is the only treatment available for prostate cancer. That is not always the case. For appropriately selected patients, advanced radiation treatment such as SBRT can treat prostate cancer without an incision, surgery or prolonged hospital stay."

"Every patient is different. We consider the patient's age, stage of cancer, risk category, overall health and personal preferences before recommending treatment. Using advanced image guidance and the Versa HD platform, radiation can be delivered with high precision while protecting nearby organs such as the bladder and rectum. The treatment can be completed in five sessions for suitable patients, making it especially helpful for elderly patients and those who may not be ideal candidates for surgery. HCG Cancer Hospital Mumbai has treated patients across intermediate-risk, high-risk and selected metastatic prostate cancer categories. Most patients treated were between 60 and 75 years of age, while approximately 20 patients were between 75 and 85 years," Dr Basu added.

Mr Rupesh Choubey, Regional COO, Healthcare Global Enterprises Ltd (Maharashtra & Madhya Pradesh), said, "With over 35 years of experience and India's largest dedicated cancer hospital network, HCG has consistently focused on making advanced cancer care accessible. At HCG Mumbai, technologies such as Versa HD and Mumbai's first and only CyberKnife are backed by a multidisciplinary team of oncology specialists, medical physicists and radiation therapists. Technology is only one part of the equation; better outcomes depend on clinical expertise, precise treatment planning and appropriate patient selection. Our focus is to bring these capabilities together to deliver personalised, patient-centric cancer care."

Mr Avik Chauhan, Cluster COO, HCG Cancer Hospitals, Mumbai said, "Treating more than 125 prostate cancer patients with advanced radiation therapy is an important milestone for HCG Mumbai. This reflects our ability to offer patients less invasive and more convenient treatment options. With experienced oncology specialists and advanced platforms such as Versa HD and CyberKnife, we combine clinical expertise with technology to deliver the right treatment to the right patient. We remain committed to strengthening our capabilities and advancing precision, comfort and the overall patient experience."

Sharing his experience, Ashok Thusu said, "When I was diagnosed with prostate cancer, my first thought was that I would need surgery and a long hospital stay. I was worried about the treatment and how it would affect my family and everyday life. The doctors at HCG explained my treatment options and told me that I was suitable for a treatment that did not require surgery. I was able to complete my radiation sessions and return home after each session. The support and reassurance from the doctors and staff gave me confidence throughout my treatment, and I am grateful for the care I received."

Another patient, Dr. Shailesh Pathak said, "When I was diagnosed with cancer, I felt as though my life had suddenly stopped. I was worried about pain, surgery and becoming dependent on my family. When the doctors explained that my treatment could be completed without an operation or a prolonged hospital stay, I felt hopeful again. The treatment was much more comfortable than I had imagined. The team explained every step, answered all my questions and supported me throughout the journey. Their care made me feel like a person, not just a patient."

Through this milestone, HCG Cancer Hospital Mumbai aims to increase awareness that surgery is not the only treatment option for prostate cancer. Patients should consult a qualified oncology team to understand whether surgery, radiation, hormone therapy or a combination of treatments is most appropriate for their individual condition.

About HCG Cancer Hospital Mumbai

HCG Cancer Hospital Mumbai provides comprehensive cancer care through a multidisciplinary team of specialists supported by advanced diagnostic, surgical and radiation technologies. Its radiation oncology capabilities include Versa HD, Image-Guided Radiation Therapy, SBRT and CyberKnife, enabling doctors to develop precise and personalised treatment plans for suitable patients.

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.